UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The type I IFN signature as a biomarker of preclinical rheumatoid arthritis

Annals of the rheumatic diseases, 2013-05, Vol.72 (5), p.776-780

2013

Volltextzugriff (PDF)

Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients

Arthritis & rheumatology (Hoboken, N.J.), 2010-12, Vol.62 (12), p.3607-3614

2010

Volltextzugriff (PDF)

Effect of prednisone on type I interferon signature in rheumatoid arthritis: consequences for response prediction to rituximab

Arthritis research & therapy, 2015-03, Vol.17 (1), p.78-78, Article 78

2015

Volltextzugriff (PDF)

Changes in peripheral blood lymphocyte subsets during arthritis development in arthralgia patients

Arthritis research & therapy, 2016-09, Vol.18 (1), p.205-205, Article 205

2016

Volltextzugriff (PDF)

Methotrexate Normalizes Up‐Regulated Folate Pathway Genes in Rheumatoid Arthritis

Arthritis & rheumatology (Hoboken, N.J.), 2013-11, Vol.65 (11), p.2791-2802

2013

Volltextzugriff (PDF)

Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patients

PloS one, 2008-04, Vol.3 (4), p.e1927-e1927

2008

Volltextzugriff (PDF)

Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141(+) Dendritic Cells and Enhanced Cross-Presentation

Cancer immunology research, 2015-05, Vol.3 (5), p.495-505

2015

Volltextzugriff (PDF)

Genetic influence on cytokine production and fatal meningococcal disease

The Lancet (British edition), 1997-01, Vol.349 (9046), p.170-173

1997

Volltextzugriff (PDF)

The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients

Arthritis research & therapy, 2012-04, Vol.14 (2), p.R95-R95, Article R95

2012

Volltextzugriff (PDF)

Transcription profiling of rheumatic diseases

Arthritis research & therapy, 2009-01, Vol.11 (1), p.207-207

2009

Volltextzugriff (PDF)

Anti-TNF therapy in RA—towards personalized medicine?

Nature reviews. Rheumatology, 2011-03, Vol.7 (3), p.136-138

Verweij, Cornelis L.

2011

Volltextzugriff (PDF)

Pharmacogenetics: Anti-TNF therapy in RA--towards personalized medicine?

Nature reviews. Rheumatology, 2011-03, Vol.7 (3), p.136

Verweij, Cornelis L

2011

Volltextzugriff (PDF)

Type I interferon response gene expression in established rheumatoid arthritis is not associated with clinical parameters

Arthritis research & therapy, 2016-12, Vol.18 (1), p.290-290, Article 290

2016

Volltextzugriff (PDF)

Pillars Article: Cyclosporin A Specifically Inhibits Function of Nuclear Proteins Involved in T Cell Activation. Science . 1989. 246: 1617-1620

The Journal of immunology (1950), 2018-12, Vol.201 (11), p.3149

2018

Volltextzugriff (PDF)

Moving towards personalized medicine in rheumatoid arthritis

Arthritis research & therapy, 2014-05, Vol.16 (3), p.110-110, Article 110

2014

Volltextzugriff (PDF)

The type I interferon signature in leukocyte subsets from peripheral blood of patients with early arthritis: a major contribution by granulocytes

Arthritis research & therapy, 2016-07, Vol.18 (1), p.165-165, Article 165

2016

Volltextzugriff (PDF)

Effect of Redox Balance Alterations on Cellular Localization of LAT and Downstream T-Cell Receptor Signaling Pathways

Molecular and Cellular Biology, 2002-01, Vol.22 (2), p.400-411

2002

Volltextzugriff (PDF)

A multi-parameter response prediction model for rituximab in rheumatoid arthritis

Joint, bone, spine : revue du rhumatisme, 2018-03, Vol.85 (2), p.219-226

2018

Volltextzugriff (PDF)

Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment

Arthritis research & therapy, 2010-01, Vol.12 (1), p.R11-R11, Article R11

2010

Volltextzugriff (PDF)

Relevance of the type I interferon signature in multiple sclerosis towards a personalized medicine approach for interferon-beta therapy

Discovery medicine, 2013-01, Vol.15 (80), p.51-60

2013

Volltextzugriff (PDF)

B cell signature contributes to the prediction of RA development in patients with arthralgia

Annals of the rheumatic diseases, 2015-09, Vol.74 (9), p.1786-1788

2015

Volltextzugriff (PDF)

07.01 A multi-parameter response prediction model for rituximab in rheumatoid arthritis

Annals of the rheumatic diseases, 2017-03, Vol.76 (Suppl 1), p.A67

2017

Volltextzugriff (PDF)

Predicting the future of anti-tumor necrosis factor therapy

Arthritis research & therapy, 2009-01, Vol.11 (3), p.115-115

Verweij, Cornelis L

2009

Volltextzugriff (PDF)

Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases

Arthritis research & therapy, 2016-02, Vol.18 (48), p.49-49, Article 49

2016

Volltextzugriff (PDF)

New insight in the mechanism of action of rituximab: the interferon signature towards personalized medicine

Discovery medicine, 2011-09, Vol.12 (64), p.229-236

2011

Volltextzugriff (PDF)

1 – 25 von 124

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(102)

Publikationsform

Sprache

Englisch
(124)

Erscheinungsjahr

n.n

Thema

Humans
(85)
Science & Technology
(71)
Life Sciences & Biomedicine
(70)
Rheumatology
(35)
Biological And Medical Sciences
(33)
Female
(32)
Middle Aged
(32)
Male
(30)
Adult
(28)
Medical Sciences
(24)
Rheumatoid Arthritis
(23)
Aged
(21)
Immunology
(19)
Diseases Of The Osteoarticular System
(17)
Arthritis, Rheumatoid - Immunology
(16)
Base Sequence
(16)
Gene Expression
(16)
Inflammatory Joint Diseases
(16)
Arthritis, Rheumatoid - Drug Therapy
(15)
Arthritis, Rheumatoid - Genetics
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The type I IFN signature as a biomarker of preclinical rheumatoid arthritis

Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients

Effect of prednisone on type I interferon signature in rheumatoid arthritis: consequences for response prediction to rituximab

Changes in peripheral blood lymphocyte subsets during arthritis development in arthralgia patients

Methotrexate Normalizes Up‐Regulated Folate Pathway Genes in Rheumatoid Arthritis

Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patients

Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141(+) Dendritic Cells and Enhanced Cross-Presentation

Genetic influence on cytokine production and fatal meningococcal disease

The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients

Transcription profiling of rheumatic diseases

Anti-TNF therapy in RA—towards personalized medicine?

Pharmacogenetics: Anti-TNF therapy in RA--towards personalized medicine?

Type I interferon response gene expression in established rheumatoid arthritis is not associated with clinical parameters

Pillars Article: Cyclosporin A Specifically Inhibits Function of Nuclear Proteins Involved in T Cell Activation. Science . 1989. 246: 1617-1620

Moving towards personalized medicine in rheumatoid arthritis

The type I interferon signature in leukocyte subsets from peripheral blood of patients with early arthritis: a major contribution by granulocytes

Effect of Redox Balance Alterations on Cellular Localization of LAT and Downstream T-Cell Receptor Signaling Pathways

A multi-parameter response prediction model for rituximab in rheumatoid arthritis

Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment

Relevance of the type I interferon signature in multiple sclerosis towards a personalized medicine approach for interferon-beta therapy

B cell signature contributes to the prediction of RA development in patients with arthralgia

07.01 A multi-parameter response prediction model for rituximab in rheumatoid arthritis

Predicting the future of anti-tumor necrosis factor therapy

Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases

New insight in the mechanism of action of rituximab: the interferon signature towards personalized medicine

Suchergebnisse filtern